FAQS About Wegovy

Yes, Wegovy is FDA-approved for chronic weight management in adults who are overweight or have obesity. At Elite Primary Care, our skilled team evaluates whether this medication is appropriate for each patient’s health goals and medical profile.

Most patients begin noticing reduced hunger or feeling full within the first week or two. Significant weight loss typically occurs over 4 to 12 weeks as doses are gradually increased. Elite Primary Care monitors progress to ensure safe and effective results.

The typical starting dose is 0.25 mg once weekly to help the body adjust. Your Elite Primary Care team may adjust this gradually to minimize side effects and optimize effectiveness.

Yes, your provider at Elite Primary Care will customize dose adjustments over time based on your response and tolerance, ensuring safety and maximum benefits.

If a dose is missed, follow instructions from your Elite Primary Care provider. They will guide you on how to resume safely without increasing side effect risks or disrupting the weekly schedule.

Wegovy is a once-weekly subcutaneous injection that can be administered at any time of day, with or without food. Elite Primary Care provides detailed guidance to ensure proper technique and adherence.

Beyond appetite control, Wegovy may help regulate blood sugar in patients with type 2 diabetes or metabolic risk factors. Elite Primary Care tracks markers like blood glucose, cholesterol, and blood pressure during treatment.

Wegovy, Ozempic, and Mounjaro are all GLP-1 receptor agonists, but Wegovy is specifically FDA-approved for chronic weight management. Your Elite Primary Care team can review which option aligns best with your health profile.

Yes, in addition to weight loss, Wegovy may support improvements in high blood pressure, type 2 diabetes, and cholesterol when combined with lifestyle modifications. Elite Primary Care integrates these considerations into individualized care plans.

The most frequent side effects are mild gastrointestinal symptoms such as nausea, vomiting, diarrhea, or constipation. These usually diminish over time. Elite Primary Care monitors and manages any adverse effects closely.

Wegovy is not recommended for patients with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or prior allergic reactions to semaglutide. Pregnant women or those planning pregnancy should avoid it. Elite Primary Care screens patients carefully before prescribing.

Yes, but interactions may occur. Elite Primary Care reviews your full medication list to safely integrate Wegovy with other treatments and monitor for potential complications.

Rarely, Wegovy can cause allergic reactions such as rash, swelling, or difficulty breathing. Immediate medical attention is recommended if these occur. Elite Primary Care provides guidance on recognizing and responding to these reactions.

Elite Primary Care schedules regular follow-ups to track weight, appetite, blood sugar, and other health markers. This monitoring allows dose adjustments and ensures long-term safety throughout your treatment.

A consultation with Elite Primary Care is required to evaluate eligibility, discuss risks and benefits, and create a personalized weight management plan. The prescription is provided if Wegovy is deemed appropriate for your health needs.

For more information, contact us or schedule an appointment online. We are conveniently located at 801 Toll House Avenue, Suite E1, Frederick MD 21701. We serve patients from Frederick MD, Mt Pleasant MD, Braddock Heights MD, Walkersville MD, Lewistown MD, Urbana MD, Ballenger Creek MD, and surrounding areas.